Drs. Lewis Lanier and Oscar Aguilar of UCSF discuss new horizons in cellular therapy to fight cancer.
Three CRI ImmunoAdvocates discuss redefining and navigating their lives after cancer immunotherapy.
By monitoring a variety of factors, especially at the genetic and genomic levels, blood tests may give doctors deep insights into a person’s cancer and their immune health.
Dr. Kunle Odunsi of Roswell Park discusses what might lie ahead for the field in 2021—and what it means for patients.
Discover the microscopic organisms that inhabit our bodies and new microbiome-based treatment strategies in the clinic.
Discover how doctors and patients can recognize and safely manage an overstimulated or misdirected immune response with Dr. Jeffrey S. Weber of NYU Langone Health.
Discover the full potential of genome-based medicine with genomic and genetic testing for cancer risk and tumor assessment with Corrie Painter, Ph.D., and Eliezer Van Allen, M.D.
Discover antibody-based imaging strategies that help doctors visualize patients’ tumors and immune cells in real-time via PET scans.
Dr. Padmanee Sharma of MD Anderson discusses what breakthroughs and advances might lie ahead for the field of cancer immunotherapy in 2020.
Dr. Michel Sadelain of Memorial Sloan Kettering highlights a revolutionary new treatment approach—CAR T cell immunotherapy—that he helped pioneer.
Brendan Connors and his oncologist Dr. Michael Postow of Memorial Sloan Kettering discuss the importance of communication between patient and doctor throughout immunotherapy treatment.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
This September for Childhood Cancer Awareness Month, we look at new research, new treatments, and how we are working toward a future immune to childhood cancer.
This September for Gynecologic Cancer Awareness Month, we reflect on new treatments, research discoveries, and how CRI is making its impact on a future immune to cervical, ovarian, and uterine cancers.